Reduction of norepinephrine versus vasopressin in the stabilization phase of septic shock: RENOVA clinical trial Cássio Mallmann; Thizá Maria Bianchi Galiotto; Michele Salibe de Oliveira; Rafael Barberena Moraes;

Factors associated with vasoplegic shock in the postoperative period of cardiac surgery and influence on morbidity and mortality of the use of arginine vasopressin as rescue therapy María Barrera Sánchez; Cristina Royo Villa; Pablo Ruiz de Gopegui Miguelena; Pablo Gutiérrez Ibañes; Andrés Carrillo López;

Clinical management of postcardiotomy shock in adults J.L. Pérez Vela; C. Llanos Jorge; J. Duerto Álvarez; J.J. Jiménez Rivera;